Hospital Puerta de Hierro-Majadahonda

Madrid 28222

0 studies enrolling now · 11 studies all time

What they study most

Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Advanced Hepatocellular Carcinoma (HCC), Chronic Lymphocytic Leukemia, Graft Rejection, Heart Failure, Hepatitis C, Hepatocellular Cancer, Hepatocellular Carcinoma, Metastatic Castration Resistant Prostate Cancer, Myelodysplastic Syndrome, Non-Alcoholic Steatohepatitis (NASH)

Studies at this site

• A Longitudinal Observational Study of the Natural History and Management of Patients With HCC — Running, not enrolling
• Reducing Lung CongestIon Symptoms in Advanced Heart Failure — Running, not enrolling
• A Randomized, Placebo-controlled, Double-blind Phase 2 Study With OSI-906 in Patients With Advanced HCC — Stopped early
• Phase 2b Study in NASH to Assess IVA337 — Completed
• A Study of Rucaparib in Patients With Metastatic Castration-resistant Prostate Cancer and Homologous Recombination Gene Deficiency — Completed
• Study to Assess Safety & Efficacy of GKT137831 in Patients With Primary Biliary Cholangitis Receiving Ursodiol. — Completed
• Safety and Efficacy of ATIR101 as Adjunctive Treatment to Blood Stem Cell Transplantation From a Haploidentical Family Donor Compared to Post-transplant Cyclophosphamide in Patients With Blood Cancer — Stopped early
• Direct Acting Antiviral-Post Authorization Safety Study — Completed
• Efficacy and Safety of Idelalisib in Combination With Ofatumumab for Previously Treated Chronic Lymphocytic Leukemia — Stopped early
• Efficacy and Safety Study of Clonidine Lauriad® to Treat Oral Mucositis — Completed
• Efficacy and Safety of Everolimus in Recipients of Heart Transplants to Prevent Acute and Chronic Rejection — Completed